Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NBIX

Recent news which mentions NBIX

< Previous 1 2 3 4 5 Next >
Why Neurocrine Biosciences Stock Sank Today
Tickers NBIX UBS
Tags Recent Press Releases Market News UBS
From Motley Fool
Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?
Tickers AVTR EL IEX ILMN
Tags PTC NBIX EL
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tickers ALMS CDT CYTH DOCS
Tags CDT RNXT GUTS
From Benzinga
Why Is Neurocrine Biosciences Stock Trading Lower On Friday?
Tickers NBIX NEWS
Tags General NBIX Stories That Matter
From Benzinga
Neurocrine Biosciences Reports Mixed Q4
Tickers NBIX TEVA
Tags NBIX Recent Press Releases Market News
From Motley Fool
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tickers ALMS DOCS FBLG GUTS
Tags HSDT NBIX TNFA
From Benzinga
Earnings Summary: Neurocrine Biosciences Q4
Tickers NBIX
Tags NBIX BZI/Recaps Market News
From Benzinga
Earnings Scheduled For February 6, 2025
Tickers AAMI AB AFRM AGCO
Tags PTON NMIH MTX
From Benzinga
Neurocrine Biosciences Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Tickers NBIX
Tags Benzinga Market News BZI/AAR
From Benzinga
Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights
Tickers NBIX NEWS TAK
Tags Market News Contracts Health Care
From Benzinga
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Tickers BIRK CHWY DOCS DRI
Tags Benzinga Stories That Matter LI
From Benzinga
What Analysts Are Saying About Neurocrine Biosciences Stock
Tickers NBIX
Tags Analyst Ratings BZI/AAR NBIX
From Benzinga
Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential
Tickers CRNX NBIX NEWS
Tags Benzinga Stories That Matter Biotech
From Benzinga
Screening For Black Friday Bargains In The Stock Market
Tickers EXPE NBIX NVDA SUPN
Tags TSLA EXPE Expert Ideas
From Benzinga
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
Tickers ABBV BMY NBIX NEWS
Tags Analyst Ratings BMY Analyst Color
From Benzinga
In-Depth Examination Of 20 Analyst Recommendations For Neurocrine Biosciences
Tickers NBIX
Tags Market News Benzinga NBIX
From Benzinga
Critical Insights From Neurocrine Biosciences Analyst Ratings: What You Need To Know
Tickers NBIX
Tags NBIX BZI/AAR Analyst Ratings
From Benzinga
"Rule Breaker Investing" Market Cap Game Show: Throwdowns & Long-Term Wins
Tickers AMD HEI KFRC LOW
Tags LOW KFRC SHOP
From Motley Fool
Neurocrine Shifts Focus To New Schizophrenia Treatment After Luvadaxistat Trial Misses Endpoint
Tickers NBIX NEWS
Tags Biotech Benzinga Briefs
From Benzinga
Decoding 19 Analyst Evaluations For Neurocrine Biosciences
Tickers NBIX
Tags Benzinga Market News Analyst Ratings
From Benzinga
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
Tickers CRL DG GFI INTC
Tags Benzinga Stories That Matter Movers
From Benzinga
Dollar General, Temu Parent PDD And Super Micro Computer Are Among Top 10 Large Cap Losers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
Tickers COIN DG DLTR MSTR
Tags why it's moving PDD MSTR
From Benzinga
Why Neurocrine Biosciences Stock Was Tumbling This Week
Tickers NBIX
Tags Recent Press Releases Market News NBIX
From Motley Fool
Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock
Tickers NBIX NEWS
Tags News Health Care Trading Ideas
From Benzinga
NVIDIA To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Thursday
Tickers CRM CRWD EQNR HPQ
Tags Trading Ideas Pre/Market Outlook News
From Benzinga
Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results
Tickers ATPC AVAV BOF FL
Tags NBIX ATPC AVAV
From Benzinga
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
Tickers ABBV BMY NBIX NEWS
Tags Movers Biotech Benzinga
From Benzinga
US Stocks Mixed; JM Smucker Slashes Annual Guidance
Tickers ATPC BOF BSLK NBIX
Tags NBIX ATPC BOF
From Benzinga
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
Tickers ABBV BMY LLY NBIX
Tags Health Care ABBV LLY
From Benzinga
Evaluating Neurocrine Biosciences: Insights From 15 Financial Analysts
Tickers NBIX
Tags Benzinga Market News Analyst Ratings
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.